Ubs Group Ag Biomerica Inc Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Biomerica Inc stock. As of the latest transaction made, Ubs Group Ag holds 23,253 shares of BMRA stock, worth $22,090. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,253

Previous 91,692 74.64%

Holding current value

$22,090

Previous $30,000 76.67%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.27 - $0.41 $18,478 - $28,059	-68,439 Reduced 74.64%	23,253 $7,000
Q3 2024 Nov 14, 2024	BUY	$0.28 - $0.49 $25,673 - $44,929	91,692 New	91,692 $30,000
Q1 2024 May 13, 2024	BUY	$0.82 - $1.29 $22,936 - $36,082	27,971 Added 550.61%	33,051 $27,000
Q4 2023 Feb 09, 2024	BUY	$0.71 - $1.65 $1,965 - $4,568	2,769 Added 119.82%	5,080 $6,000
Q3 2023 Nov 09, 2023	BUY	$0.82 - $1.65 $972 - $1,956	1,186 Added 105.42%	2,311 $1,000
Q2 2023 Aug 11, 2023	SELL	$1.12 - $1.87 $369 - $617	-330 Reduced 22.68%	1,125 $1,000
Q1 2023 May 12, 2023	SELL	$1.86 - $3.56 $887 - $1,698	-477 Reduced 24.69%	1,455 $2,000
Q4 2022 Feb 08, 2023	BUY	$2.98 - $4.17 $1,710 - $2,393	574 Added 42.27%	1,932 $6,000
Q3 2022 Nov 10, 2022	BUY	$2.61 - $3.98 $3,544 - $5,404	1,358 New	1,358 $5,000
Q2 2022 Aug 10, 2022	SELL	$2.7 - $4.69 $6,520 - $11,326	-2,415 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.59 - $4.64 $3,686 - $4,765	1,027 Added 73.99%	2,415 $11,000
Q4 2021 Feb 14, 2022	BUY	$3.89 - $6.71 $5,399 - $9,313	1,388 New	1,388 $5,000
Q3 2021 Nov 15, 2021	SELL	$3.54 - $5.13 $3,270 - $4,740	-924 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.41 - $5.9 $3,150 - $5,451	924 New	924 $4,000
Q4 2020 Feb 11, 2021	SELL	$4.71 - $7.85 $9,420 - $15,700	-2,000 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$5.86 - $12.04 $2,930 - $6,020	-500 Reduced 20.0%	2,000 $14,000
Q2 2020 Jul 31, 2020	BUY	$5.17 - $8.95 $7,020 - $12,154	1,358 Added 118.91%	2,500 $18,000
Q1 2020 May 01, 2020	BUY	$2.37 - $16.0 $2,706 - $18,272	1,142 New	1,142 $8,000
Q2 2019 Aug 14, 2019	SELL	$2.19 - $2.7 $3,107 - $3,831	-1,419 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.92 - $2.85 $2,724 - $4,044	1,419 New	1,419 $4,000
Q4 2018 Feb 14, 2019	SELL	$1.7 - $3.58 $3,903 - $8,219	-2,296 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.35 - $4.14 $2,948 - $3,643	-880 Reduced 27.71%	2,296 $8,000
Q2 2018 Aug 14, 2018	BUY	$3.41 - $4.21 $4,876 - $6,020	1,430 Added 81.9%	3,176 $12,000
Q1 2018 May 15, 2018	BUY	$3.81 - $5.3 $6,652 - $9,253	1,746 New	1,746 $7,000
Q4 2017 Feb 14, 2018	SELL	$2.72 - $4.43 $587 - $956	-216 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.6 - $2.9 $561 - $626	216 New	216 $1,000
Q2 2017 Aug 14, 2017	SELL	N/A	-305 Closed	0 $0
Q1 2017 Nov 14, 2017	BUY	N/A	305	305 $1,000

Others Institutions Holding BMRA

# of Institutions

Shares Held

1.59M

Call Options Held

23.3K

Put Options Held

View Full List

About BIOMERICA INC

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $12.8M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

More about BMRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account